Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lifecore Biomedical Inc shares valued at $7,411,562 were sold by English Aron R. on May 27 ’25. At $6.50 per share, English Aron R. sold 1,139,504 shares. The insider’s holdings dropped to 414,599 shares worth approximately $3.25 million following the completion of this transaction.
Also, English Aron R. sold 150,419 shares, netting a total of over 1,071,555 in proceeds. Following the sale of shares at $7.12 each, the insider now holds 264,180 shares.
Before that, English Aron R. had sold 96,137 shares from its account. In a trade valued at $649,386, the 10% Owner traded Lifecore Biomedical Inc shares for $6.75 each. Upon closing the transaction, the insider’s holdings decreased to 96,137 shares, worth approximately $12.17 million.
As published in their initiating research note from KeyBanc Capital Markets on September 04, 2025, Lifecore Biomedical Inc [LFCR] has been a Sector weight. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late May. As of September 05, 2024, Craig Hallum has initiated its “Buy” rating for LFCR. Earlier on August 28, 2024, Barrington Research downgraded its rating. Their new recommendation was “a Mkt perform” for LFCR stock which previously was a “an Outperform”.
Analyzing LFCR Stock Performance
On last trading session, Lifecore Biomedical Inc [NASDAQ: LFCR] plunged -0.89% to $7.83. The stock’s lowest price that day was $7.7354, but it reached a high of $7.92 in the same session. During the last five days, there has been a surge of approximately 4.54%. Over the course of the year, Lifecore Biomedical Inc shares have jumped approximately 7.11%. Shares of the company reached a 52-week high of $8.85 on 07/11/25 and a 52-week low of $4.76 on 04/07/25.
Support And Resistance Levels for Lifecore Biomedical Inc (LFCR)
According to the 24-hour chart, there is a support level at 7.74, which, if violated, would cause prices to drop to 7.64. In the upper region, resistance lies at 7.92. The next price resistance is at 8.01. RSI (Relative Strength Index) is 58.53 on the 14-day chart, showing neutral technical sentiment.
Is Lifecore Biomedical Inc subject to short interest?
Stocks of Lifecore Biomedical Inc saw a sharp rise in short interest on 2025-11-14 jumping by 15143.0 shares to 2.76 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 2.75 million shares. A jump of 0.55% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 16.76 of the overall float, the days-to-cover ratio (short ratio) jumped to 16.76.
Which companies own the most shares of Lifecore Biomedical Inc (LFCR)?
In terms of Lifecore Biomedical Inc share price expectations, FactSet research, analysts set an average price target of 6.5 in the next 12 months, down nearly -17.72% from the previous closing price of $7.9. Analysts anticipate Lifecore Biomedical Inc stock to reach 8 by 2025, with the lowest price target being 5. On March 20, 2023, Stephens assigned a price target of “an Equal-weight” to the stock and downgraded coverage with a $2.
